您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > GSK-3 Inhibitor IX(BIO)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
GSK-3 Inhibitor IX(BIO)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
GSK-3 Inhibitor IX(BIO)图片
CAS NO:667463-62-9
规格:98%
分子量:356.17
包装与价格:
包装价格(元)
10mg电议
50mg电议

产品介绍
GSK-3α/GSK-3β inhibitor, cell-permeable, ATP-competitive and reversible
CAS:667463-62-9
分子式:C16H10BrN3O2
分子量:356.17
纯度:98%
存储:Store at -20°C

Background:

GSK-3 inhibitor IX (BIO) is a potent, selective, cell-permeable, ATP-competitive and reversible inhibitor of GSK-3α (glycogen synthase kinase-3α) and GSK-3β (lycogen synthase kinase-3β) (IC50 = 5nM for GSK-3β). [1]


GSK3 (glycogen synthase kinase-3) is a serine/threonine protein kinase which contributes to cell survival, diabetes, insulin resistance and Alzheimer's diseases. It is contributed to β-catenin/Wnt signaling pathway.


BIO facilitated the proliferation in mammalian cardiomyocytes by increasing the proliferation potential of cardiomyocytes. It induced S phase entry and beta-catenin activity in neonatal cardiomyocyte. [3] BIO also activated Wnt signaling and involved in maintaining pluripotency in human and mouse ESCs (embryonic stem cells). [2] In Cos-1 cells treated with 5 μm BIO for 24 hours, phosphorylation of β-catenin was inhibited on GSK-3 specific sites. In cell line deficient for AhR or ARNT, 10 μm BIO treatment for 24 hours showed its effect is through a direct and AhR- independent pathway.[1]


In vivo study showed BIO activated maternal Wnt signaling pathway in Xenopus embryos. It caused a hyper dorso-anteriorization at the expense of trunk and tail in a dose-response manner. It also activated the dorsal genes (siamois and chordin) ectopically. [1]


参考文献:
[1] Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, Crovace C, Tarricone C, Musacchio A, Roe SM, Pearl L, Greengard P.  GSK-3-selective inhibitors derived from Tyrian purple indirubins.  Chem Biol. 2003 Dec;10(12):1255-66.
[2] Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.  Nat Med. 2004 Jan;10(1):55-63. 
[3] Tseng AS, Engel FB, Keating MT.  The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.  Chem Biol. 2006 Sep;13(9):957-63.